Endothelin antagonists

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/06 (2006.01) A61K 38/08 (2006.01) C07K 5/107 (2006.01) C07K 14/575 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2146874

Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid, hemorrhage, arrhythmias, asthma, preeclampsia Raynaud's disease, percutaneous transluminal coronary angioplasty or restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, ischemic bowel disease, and diabetes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1374987

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.